Protein and peptide parenteral controlled delivery

Bibliography

• FU K, KLIBANOV AM, LANGER R: Protein stability in controlled-release systems. Nat. Biotechnol (2000) 18(1):24–25.
   PubMed Web of Science ®Google Scholar
• DAS RC: Progress and prospects of protein therapeutics. American Biotechnology Laboratory (2003):8–12.
   Google Scholar
• VLADIMIR PT, ANATOLY NL: Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov. Today (2003) 8(6):259–266.
   PubMed Web of Science ®Google Scholar
• GOZES I: Neuroprotective peptide drug delivery and development: potential new therapeutics. Trends NeuroscL (2001) 24(12):700–705.
   PubMed Web of Science ®Google Scholar
• MAEDA H: SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Delivery Rev. (2001) 46:169–185.
   PubMed Web of Science ®Google Scholar
• FRANCI CR, ANSELMO-FRANCI JA, MCCANN SM: The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone. Proc. Natl. Acad. Sri. USA. (1992) 89(23):11391–11395.
   PubMed Web of Science ®Google Scholar
• VAN DEN BERGHE G, WOUTERS P, WEEKERS F et al: Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. I Clin. Endocrinol Metab. (1999) 84(4):1311–1323.
   PubMed Web of Science ®Google Scholar
• HANSEN L, HARTMANN B, BISGAARD T, MINE0 H, JORGENSEN PN, HOLST JJ: Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum. Am. J. Physiol Endocrinol Metab. (2000) 278(60):E1010–E1018.
   PubMedGoogle Scholar
• CALES P, MASLIAH C, BERNARD B: Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl. J. Med. (2001) 344:23–28.
   PubMed Web of Science ®Google Scholar
• BRADER ML, SUKUMAR M, PEKAR AH et al: Hybrid insulin cocrystals for controlled-release delivery. Nat. Biotechnol (2002) 20(8):800–804.
   PubMed Web of Science ®Google Scholar
• VILLALOBOS C, NUNEZ L, FRAWLEY LS, GARCIA-SANCHO J, SANCHEZ A: Multi-responsiveness of single anterior pituitary cells to hypothalamic-releasing hormones: Aacellular basis for paradoxical secretion. Proc. Natl. Acad. Sri. USA (1997) 94:14132–14137.
   PubMed Web of Science ®Google Scholar
• STOLL BR, LEIPOLD HR, MILSTEIN S, EDWARDS DA: A mechanistic analysis of carrier-mediated oral delivery of protein therapeutics. J. Control. Release (2000) 64:217–228.
   PubMed Web of Science ®Google Scholar
• GORDON SJ: Development of oral insulin: progress and current status. Diabetes/ metabolism Res. Rev (2002) 18:29–37.
   Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• XU Y, DU Y: Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm. (2003) 250:215–226.
   PubMed Web of Science ®Google Scholar
• CARINO GP, JACOB JS, MATHIAUTZ E: Nanosphere based on oral insulin delivery. Control. Release (2000) 65:261–269.
   PubMed Web of Science ®Google Scholar
• PROKOP A, HOLLAND CA, KOZLOV E, MOORE B, TANNER RD: Water-based nanoparticles polymeric system for protein delivery. Biotechnol Bioeng. (2001) 75(2):228–232.
   PubMed Web of Science ®Google Scholar
• GOLDBERG M, GOMEZ-ORELLANA I: Challenges for the oral delivery of macromolecules. Nat. Rev Drug Discov (2003) 2:289–295.
   PubMed Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• SHAH RB, AHSAN F, KHAN MA: Oral delivery of proteins: progress and prognostication. Grit. Rev Ther. Drug Carrier Syst. (2002) 19:135–169.
   PubMed Web of Science ®Google Scholar
• LEE HJ: Protein drug oral delivery: the recent progress. Arch. Pharm. Res. (2002) 25:572–584.
   PubMed Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• SOOD A, PANCHAGNULA R: Peroral route: an opportunity for protein and peptide drug delivery. Chem. Rev. (2001) 101:3275–3303.
   PubMed Web of Science ®Google Scholar
• MAHATO RI, NARANG AS, THOMA L, MILLER DD: Emerging trends in oral delivery of peptide and protein drugs. Grit. Rev Ther. Drug Carrier Syst. (2003) 20(2-3):153–214.
   PubMed Web of Science ®Google Scholar
• YOUNES HM, AMSDEN BG: Interferon-gamma therapy: evaluation of routes of administration and delivery systems. Pharm. Sd. (2002) 91:2–17.
   PubMed Web of Science ®Google Scholar
• PATTON JS: Deep-lung delivery of therapeutic proteins. Chemtech. (1997) 27(12):34–38.
   Google Scholar
• ELIAZ RE, KOST J: Characterization of a polymeric PLGA-injectable implant delivery system for the controlled-release of proteins. Biomed. Mater. Res. (2000) 50:388–396.
   PubMed Web of Science ®Google Scholar
• BAJPAI SK, SONKUSLEY J: Hydrogels for oral drug delivery of peptides: synthesis and characterization. I Appl. Polym. Sri. (2002) 83:1717–1729.
   Web of Science ®Google Scholar
• ANDRIANOV AK, PAYNE LG: Protein release from polyphosphazene matrices. Adv. Drug Deify. Rev (1998) 31:186–196.
   Google Scholar
• DORKOOSH FA, COOS VERHOEF J, AMBAGTS MH, BORCHARD G, RAFIEE-TEHRANI M, JUNGINGER HE: Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin. Ear: J. Pharm. ScL (2002) 15:433–439.
   PubMed Web of Science ®Google Scholar
• DORKOOSH FA, VERHOEF JC, BORCHARD G, RAFIEE-TEHRANI M, JUNGINGER HE: Evaluation of superporous hydrogel (SPH) and SPH composite in porcine intestine ex vivo: assessment of drug transport, morphology effect, and mechanical fixation to intestinal wall. Eur. I Pharm. Biopharm. (2002) 53:161–166.
   PubMed Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• MELLOTT MB, SEARCY K, PISHKO MV: Release of protein from highly cross-linked hydrogels of poly(ethylene glycol) diacrylate fabricated by UV polymerization. Biomaterials (2001) 22:929–941.
   PubMed Web of Science ®Google Scholar
• PUTNEY SD, BURKE PA: Improving protein therapeutics with sustained-release formulations. Nat. Biotechnol (1998) 16:153–157.
   PubMed Web of Science ®Google Scholar
• MORLOCK M, KOLL H, WINTER G, KISSEL T: Microencapsulation of rh-erythropoietin, using poly (D,L-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Ear: Pharm. Biopharm. (1997) 43:29–36.
   Web of Science ®Google Scholar
• KLIBANOV AM: Improving enzymes by using them in organic solvents. Nature (2001) 409:241–246.
   PubMed Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• HOWDLE SM, WATSON MS, WHITAKER MJ et al: Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials. Chem. Comm. (2001):109–110.
   Web of Science ®Google Scholar
• HILDEBRAND GE, TACK JW: Microencapsulation of peptides and proteins. hat. Pharm. (2000) 196(2):173–176.
   Google Scholar
• HAECKEL S, SACHSE A, ALBAYRAK C, MILLER RH: Preperation and characterization of insulin-loaded microcapsules produced by the induced phase separation method. Proceedings of The Second World Meeting APCl/APV Paris, France (1998).
   Google Scholar
• PEREZ C, CASTELLANOS IJ, COSTANTINO HR, AL-AZZAM W, GRIEBENOW K: Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. Pharm. Pharmacol (2002) 54:301–313.
   PubMed Web of Science ®Google Scholar
• VAN DE WEERT M, HOECHSTETTERJ, HENNINK WE, CROMMELIN DJ: The effect of a water/ organic solvent interface on the structural stability of lysozyme. Control. Release (2000) 68:351–359.
   PubMed Web of Science ®Google Scholar
• KANG F, JIANG G, HINDERLITER A,DELUCA PP, SINGH J: Lysozyme stability in primary emulsion for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients. Pharm. Res. (2002) 19:629–633.
   PubMed Web of Science ®Google Scholar
• CARRASQUILLO KG, STANLEY AM,APONTE-CARRO JC et al.: Non-aqueous encapsulation of excipient-stabilized spray freeze-dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J. Control. Release (2001) 76:199–208.
   Google Scholar
• LI MX, ZHUO RX, QU F: Study on the preparation of novel functional poly (dioxanone) and for the controlled-release of protein. React. Funct. Polym. (2003) 55(2):185–195.
   Web of Science ®Google Scholar
• KAWASHIMA Y: Nanoparticulate systems for improved drug delivery. Adv. Drug Deliv. Rev (2001) 47(1):1–2.
   PubMed Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• JANES KA, ALONSO MJ: Depolymerized chitosan nanoparticles for protein delivery: preparation and characterization. I Appl Polym. Sci. (2003) 88:2769–2776.
   Web of Science ®Google Scholar
• TAKEUCHI H, YAMAMOTO H, KAWASHIMA Y: Muroadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deify. Rev (2001) 47(1):39–54.
   PubMed Web of Science ®Google Scholar
• SCHWENDEMAN SP: Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Grit. Rev Ther. Drug Carrier Syst. (2002) 19(1):73–98.
   PubMed Web of Science ®Google Scholar
• TAKEUCHI H, YAMAMOTO H, NIWA T, HINO T, KAWASHIMA Y: Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm. Res. (1996) 13:896–901.
   PubMed Web of Science ®Google Scholar
• TORRES-LUGO M, PEPPAS NA: Preparation and characterization of P(MAA-g-EG) nanospheres for protein delivery applications. J. Nanoparticle Res. (2002) 89:1606–1613.
   Google Scholar
• JANES KA, FRESNEAU MP, MARAZUELA A, FABRA A, ALOSO MJ: Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release (2001) 73:255–267.
   PubMed Web of Science ®Google Scholar
• KOMPELLA UB, LEE VH: Delivery systems for penetration enhancement of peptide and protein drugs: design considerations. Adv. Drug Deify. Rev (2001) 46:211–245.
   PubMed Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• SLAGER J, DOMB AJ: Stereocomplexes based on poly (lactic acid) and insulin: formulation and release studies. Biomaterials (2002) 23(22):4389–4396.
   PubMed Web of Science ®Google Scholar
• SLAGER J, DOMB AJ: Biopolymer stereocomplexes. Adv. Drug Deify. Rev (2003) 55(4):549–583.
   PubMed Web of Science ®Google Scholar
• SLAGER J, DOMB AJ: Heterostereocomplexes prepared from D-poly(lactide) and leuprolide. I. Characterization. Biomacromolecules (2003) 4(5):1308–1315.
   PubMed Web of Science ®Google Scholar
• SLAGER J, DOMB AJ: Heterostereocomplexes prepared from D-PLA and L-PLA and leuprolide. II. Release of leuprolide. Biomacromolecules (2003) 4(5):1316–1320.
   PubMed Web of Science ®Google Scholar
• SLAGER J, COHEN Y, KHALFIN R, TALMON Y, DOMB AJ: Peptides form stereoselective complexes with chiral polymers. Macromolecules (2003) 36(9):2999–3000.
   Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• SLAGER J, DOMB AJ: Stereoselective complexes of poly(lactic acid) and leuprolide. Eur. I Pharm. Biopharm. (2004) (In Press).
   Google Scholar
• FROKJAER S, HOVGAARD L: Pharmaceutical formulation development of peptides and proteins. Frokjaer S, Hovgaard L (Eds), Taylor & Francis Ltd (2000).
   Google Scholar
• PRADILLA G, AZZAM T, WANG PP, DOMB AJ, BREM H: Gene therapy for malignant brain tumors. Expert Rev Neurotherapeutics (2003) 3(5):685–701.
   PubMedGoogle Scholar
• YOKOYAMA M: Influential factors on temperature-controlled gene expression using thermo-responsive polymeric gene carriers. I Aral Organs (2001) 4:138–145.
   Google Scholar
• CHUNG JE, YOKOYAMA M, YAMATO M, AOYAGI T, SAKURAI Y, OKANO T: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butyl methacrylate). J. Control. Release (1999) 62:115–127.
   PubMed Web of Science ®Google Scholar
• FALK MH: Hyperthermia in oncology. Int. Hyperthermia (2001) 17:1–18.
   PubMed Web of Science ®Google Scholar
• BENNS JM, CHOI JS, MAHATO RI, PARK JS, KIM SW: pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. Bioconjug. Chem. (2000) 11:637–645.
   PubMed Web of Science ®Google Scholar
• PICHON C, ROUFA MB, MONSIGNY M, MIDOUX P: Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides. Nucleic Acids Res. (2000) 28:504–512.
   PubMed Web of Science ®Google Scholar
• DASH PR, READ ML, FISHER KD et al:Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J. Biol. Chem. (2000) 275(6):3793–3802.
   PubMed Web of Science ®Google Scholar
• MEYER DE, KONG GA, DEWHIRST MW, ZALUTSKY MR, CHILKOTI A: Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res. (2001) 61(4):1548–1554.
   PubMed Web of Science ®Google Scholar
• CAPPELLO J, GHANDEHARI H: Engineered protein polymers for drug delivery and biomedical applications. Adv. Drug Deify. Rev (2002) 54:1053–1055.
   Web of Science ®Google Scholar
• AZZAM T, ELIYAHU H, SHAPIRA L, LINIAL M, BARENHOLZ Y, DOMB AJ: Polysaccharide-oligoamine based conjugates for gene delivery. J. Med. Chem. (2002) 45(9):1817–1824.
   PubMed Web of Science ®Google Scholar
• DEAN DA: Nuclear transport: an emerging opportunity for drug targeting. Adv. Drug Deliv. Rev (2003) 55:699–702.
   PubMed Web of Science ®Google Scholar
• GANORKAR CR, LIU F, BAUDYS M, KIM SW: Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight. .1. Control. Release (1999) 59:287–298.
   Google Scholar
• BURKE PA: Controlled-release protein therapeutics: effects of process and formulation on stability. In: Handbook Of Pharmaceutical Controlled Release Technology Wise DL (Ed.), Marcel Dekker, New York, USA (2000):661–692.
   Google Scholar
• HOFFMAN AS: Hydrogels for biomedical applications. Adv. Drug Deify. Rev (2002) 43:3–12.
   Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• KAMIYA N, KLIBANOV AM: Controling the rate of protein release from polyelectrolyte complexes. Biotechnol Bioeng. (2003) 82(5):590–594.
   PubMed Web of Science ®Google Scholar
• MORRIS MC, DEPOLLIER J, MERY J, HEITZ F, DIVITA G: A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol (2001) 19:1173–1176.
   PubMed Web of Science ®Google Scholar
• •Describes key issues related to protein stabilisation and delivery.
   Google Scholar
• PETTET DK, GOMBOTZ WR: The development of site specific drug-delivery systems for protein and peptide biopharmaceuticals. Tibtech. (1998) 16:343–349.
   PubMed Web of Science ®Google Scholar